4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Market Cap $52.18M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| SIO | Change in substantial holding | 12/04/18 | ||
| SIO | Ceasing to be a substantial holder from HML | 10/04/18 | ||
| SIO | SIO Appendix 4D and 1H2018 Financial report | PRICE SENSITIVE | 21/02/18 | |
| SIO | Change in substantial holding | 21/12/17 | ||
| SIO Change in substantial holding | |||
| 12/04/18 | |||
| SIO Ceasing to be a substantial holder from HML | |||
| 10/04/18 | |||
| SIO SIO Appendix 4D and 1H2018 Financial report | |||
| 21/02/18 | PRICE SENSITIVE | ||
| SIO Change in substantial holding | |||
| 21/12/17 | |||
